Humana (HUM) Change in Receivables (2009 - 2026)

Humana (HUM) has reported Change in Receivables for 18 consecutive years, with $478.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Receivables rose 962.22% year-over-year to $478.0 million in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 180.68% increase from a year earlier, with the FY2025 full-year figure at $570.0 million, down 14.8% from the prior year.
• Change in Receivables was $478.0 million for Q2 2026 at Humana, down from $1.9 billion in the prior quarter.
• Over five years, Change in Receivables peaked at $1.9 billion in Q1 2026 and troughed at -$1.9 billion in Q3 2024.
• A 5-year average of $223.4 million and a median of $384.0 million in 2022 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables plunged 592.66% in 2024 and soared 962.22% in 2026, its largest moves.
• Over 5 years, Change in Receivables stood at $65.0 million in 2022, then jumped by 224.62% to $211.0 million in 2023, then soared by 165.4% to $560.0 million in 2024, then climbed by 4.64% to $586.0 million in 2025, then dropped by 18.43% to $478.0 million in 2026.
• The last three Change in Receivables figures came in at $478.0 million (Q2 2026), $1.9 billion (Q1 2026), and $586.0 million (Q4 2025), per Business Quant data.